Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab. [PDF]
Shibutani M+5 more
europepmc +1 more source
Thymidine Phosphorylase Promotes Abdominal Aortic Aneurysm via VSMC Modulation and Matrix Remodeling in Mice and Humans. [PDF]
Hong L+12 more
europepmc +1 more source
Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE. [PDF]
Du J+7 more
europepmc +1 more source
Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE. [PDF]
Meinders M+5 more
europepmc +1 more source
Thymidine phosphorylase and prostrate cancer cell proliferation inhibitory activities of synthetic 4-hydroxybenzohydrazides: In vitro, kinetic, and in silico studies. [PDF]
Javaid S+6 more
europepmc +1 more source
Quantification of Plasma and Urine Thymidine and 2'-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy. [PDF]
Kipper K+8 more
europepmc +1 more source
Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy. [PDF]
Levene M+11 more
europepmc +1 more source
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study. [PDF]
Almandil NB+11 more
europepmc +1 more source
Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study. [PDF]
Zaman K+6 more
europepmc +1 more source
Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies. [PDF]
Javaid S+3 more
europepmc +1 more source